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1. Introduction 
There is considerable interest in the role of adeno- 
sine on the regulation of fat cell metabolism. It has 
been shown to antagonize cyclic AMP accumulation 
and inhibit lipolysis in a manner similar to that of 
prostaglandin E and nicotinic acid [l-9]. The addi- 
tion of adenosine deaminase to fat cells potentiates 
cyclic AMP accumulation and increases lipolysis 
caused by lipolytic hormones and abolishes the anti- 
lipolytic activity of insulin [6,7]. Itsinhibitory effects 
on hormone-stimulated cyclic AMP production is, 
however, greater than its effects on the increase in 
lipolysis [8,10]. Since the maximal rates of lipolysis 
require a relatively small increase in cyclic AMP con- 
centration [ 10,111, the important role of adenosine 
may be to prevent a large increase in the concentra- 
tion of cyclic AMP in fat cells rather than the inhib- 
ition of lipolysis per se [ 121. 
Cyclic AMP is produced from ATP in a reaction 
catalyzed by adenylate cyclase and, degraded by the 
enzyme cyclic AMP phosphodiesterase. Changes in 
the level of cyclic AMP could result from changes in 
the rate of one or both the reactions. In fat cells, the 
concentration of cyclic AMP rises to a peak within a 
few minutes of hormone stimulation and declines 
rapidly thereafter towards basal levels [ 13,141. The 
rapid decline could be due to an inhibition of adenyl- 
ate cyclase, as well as a stimulation of cyclic AMP 
phosphodiesterase. Adenosine has been shown to 
inhibit adenylate cyclase activity of fat cell ghosts 
[ 1 ,151 and of purified membranes of rat fat cells 
[ 161. The evidence for the involvement of adenosine 
on phosphodiesterase has, on the other hand, been 
obtained indirectly by the study of the effects of 
papavarine and dipyridamole, inhibitors of adenosine 
transport, and caffeine and theophylline, which block 
adenosine effects. Here, we show that adenosine acti- 
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vates cyclic AMP phosphodiesterase in rat fat cells. 
We propose that the effect of adenosine in reducing 
the intracellular concentration of cyclic AMP could 
be due to the concerted action of adenosine in simul- 
taneously inhibiting adenylate cyclase and activating 
cyclic AMP phosphodiesterase. 
2. Materials and methods 
Most chemicals including bovine serum albumin 
(fraction V), adenosine, collagenase (type II), cyclic 
AMP, 5’-nucleotidase from C’rotalus adamanteus 
venom (77 units/mg protein) and Hepes were 
obtained from Sigma. Labeled cyclic [3H] AMP 
(37.7 Ci/mmol) was obtained from the Radiochemical 
Centre, Amersham. 
Isolated fat cells were prepared by the collagenase 
method in [ 171 from the epididymal adipose tissues 
of fed male Sprague-Dawley rats (160-200 g). Krebs- 
Henseleit-Hepes buffer (pH 7.4) containing 2.5 mM 
calcium and 4% bovine serum albumin was used. Tis- 
sue from several animals were pooled to reduce the 
variability seen among individual animals. 
Unless otherwise noted, the fat cells were distri- 
buted into separate polyethylene vials, gassed with 
oxygen, and the vials closed tightly with rubber stop- 
pers. Cells were not preincubated before the start of 
experiments to minimise the production of adenosine 
by the cells. Experiments were usually done for 
10 min at 37°C after which the fat cells were imme- 
diately homogenised by means of Dounce tissue 
grinders (Type B pestle, 8 strokes). The homogenates 
were then centrifuged at 3000 rev./min (800 X g) for 
3 min and the infranatants assayed for phosphodies- 
terase activity. 
Cyclic AMP phosphodiesterase assays were per- 
formed with a final volume of 0.8 ml containing 
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80 mM Tris-I-K1 (pH 8.0) 3 mM nlagnesium acetate, 
0.2 mM CaCla, 0.13 /.&i cyclic [3H]AMP and 0.1 ,uM 
unlabelled cyclic AMP. The assay was done at 30°C 
for 10 min and the reaction terminated by freezing 
the tubes in a dry-ice-ethanol bath. In all the experi- 
ments, the amount of enzyme added caused hydroly- 
sis of <15% of the substrate. The frozen tubes were 
then placed in a boiling water bath for 90 s, cooled 
and to each and every tube was added 0.2 units of 
5’-nucleotidase, adenosine, to a final concentration of 
20 MM, and 10 PM 5’-AMP, and the tubes incubated 
at 30°C for a further 20 min. EDTA (0.1 ml, 50 mM) 
was added to stop the reaction. Tritiated adenosine 
was separated from the unreacted cyclic AMP by the 
method in [ 181 as modified [ 191. By this method, 
the reaction mixtures were passed over a column 
(0.7 X 2.5 cm) of quarternary aminoethyl (QAE)- 
Sephadex (A-25) in the formate form. The tubes were 
rinsed with 1 ml 20 mM ammonium formate (pH 7.4) 
which was also passed over the column, followed by 
3 ml of the same ammonium formate solution. The 
effluent (5 ml) was collected in glass scintillation vials 
and counted in 15 ml of a triton-based scintillation 
mixture. 
Dry weights of isolated fat cells were determined 
by pipetting aliquots (0.5 ml) of the fat cell suspen- 
sion onto tared (25 mm Millipore filter paper (SMWP 
02500) pre-moistened with water. The medium was 
removed by vacuum filtration and the filter paper dried 
over silica gel under reduced pressure and reweighed. 
The average of 3 determinations were used as the cell 
weight. 
Results from representative xperiments are 
shown. Data are reported as the mean of duplicate or 
triplicate incubations, which in all cases were within 
10% of each other. All observations were confirmed 
by repetition on at least 3 other occasions using dif- 
ferent batches of cells. The validity of expressing the 
results in this manner, because of the variab~ity in 
the degree of response from different batches of cells, 
has been discussed [20-221. 
3. Results and discussion 
3.1. Time course effect of adenosine on cyclic AMP 
Ph~sphodiesterQse 
The failure to observe any effects of a compound 
on the activity of an enzyme could have been due to 
the transient nature of its effects. A study of the time 
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Fig.1. Time course effect of adenosine on intact cell phos- 
phodiesterase. Fat cells (8 mgfml) were added to 20 PM aden- 
osine and incubated at 37*C for the length of time indicated. 
course effect of adenosine on the cyclic AMP phos- 
phodiesterase was therefore made. Adenosine was 
used at 20 /..IM in the experiments because it was 
shown in [8] that 10 PM adenosine had a maximum 
inhibitor effect on the accumulation of cyclic AMP 
in the presence of norepinephrine. For good measure, 
twice this concentration was used. 
Fig.1 shows that 20 PM adenosine stimulated the 
activity of the low Km cyclic AMP phospllodiesterase 
of rat fat cells. Maximum stimulation was attained 
within 10 min after the addition of adenosine, fol- 
lowed by a rapid decline towards basal activity. The 
pattern of the time course effect of adenosine stimu- 
lation of phosphodiesterase, was consistent with the 
observation that in fat cells, cyclic AMP accumulation 
reaches a peak within a short period of hormone 
stimulation, after which there is a rapid decline pre- 
sumably due to the concerted action of cyclic AMP 
phosphodiesterase and the inhibition of adenylate 
cyclase activity. 
3.2. Effect of adenosine concentration on the stinw 
lation of cyclic AMP phosphodiesterase 
Adenosine nucleosides inhibited the low Km phos- 
phodiesterase found in the supernatant fraction 
obtained aft.er centrifugation of rat fat cell homoge- 
nates [ 11. The inhibitory rather than stimulatory 
effect observed could have been due to the high con- 
centration of adenosine used, or, the observations in 
[ 11, made on the cyclic AMP phosphodiesterase in a 
cell-free system, differed from our experiments with 
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Fig.2. Effect of adenosine concentration on intact cell phos- 
phodiesterase. Fat cells (4 mg/ml) were added to various con- 
centrations of adenosine and incubated at 37°C for 10 min. 
intact cells. Experiments were done with varying 
amounts of adenosine on phosphodiesterase from 
intact cells, as well as on phosphodiesterase from 
broken cells (fig.2,3). 
Adenosine as low as 0.1 I.IM had a stimulatory 
effect on phosphodiesterase in intact cells (fig.2). This 
effect increased with increasing adenosine concentra- 
tions reaching a maximum at 10 PM. The concentra- 
tion of adenosine at which maximum stimulation of 
phosphodiesterase activity was achieved, however, 
varied from one cell preparation to another. At dilute 
cell concentrations (GO mg/ml), maximum stimula- 
tory effect was obtained with 10 FM adenosine 
(fig.2). The stimulatory effect of adenosine, however, 
appeared to diminish slightly at 100 /.LM but was never 
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Fig.3. Effect of adenosine concentration on u,oken cell 
phosphodiesterase. Fat cells (6 mg/ml) were homogenised 
and the phosphodiesterase activity determined in the pres- 
ence of various concentrations of adenosine. 
Table 1 
Cell concentration and the effect of adenosine on phospho- 
diesterase activity 
[Fat cell] PDE act. (pmol . min“. mg cells-‘) Activation 
(mg/ml) (%) 
Control 20 NM Adenosine 
7 0.146 t 0.003 0.237 f 0.006 62% 
42 0.140 * 0.007 0.192 + 0.001 38% 
Values represent the mean f SEM 
found to be inhibitory. The effect of adenosine on 
phosphodiesterase from homogenates of fat cells not 
pre-exposed to adenosine were different (fig.3). Low 
concentrations of adenosine were found to have little 
or no effect on the phosphodiesterase activity. The 
higher concentrations had an inhibitory effect similar 
to that observed in [l] with 70 /.JM adenosine, on the 
phosphodiesterase activity of the 48 000 X g super- 
natant, obtained by centrifugation of fat cell homog- 
enates. Thus it would appear that the stimulatory 
effect of adenosine on fat cell phosphodiesterase can 
be demonstrated only with intact cells as is the case 
with insulin. 
3.3. Cell concentration and the effects of adenosine 
Adenosine is continously released by fat cells into 
the incubation medium in amounts which inhibit 
cyclic AMP accumulation and lipolysis due to norepi- 
nephrine [3]. This inhibitory effect was diminished 
when dilute cell suspensions containing 20 000 fat 
cells/ml were used [23]. Adenosine deaminase 
enhanced the basal lipolytic activity of fat cells, and 
the effect was more pronounced at low cell concen- 
trations than at concentrated cell suspensions. Thus 
the stimulatory effect of adenosine on the cyclic 
AMP phosphodiesterase should be greater at low cell 
concentrations than with high cell concentrations. 
This was in fact found to be the case (table 1). Con- 
trols were done for each cell concentration used since 
the amount of adenosine released is known to 
increase with increasing cell concentrations [23 1. A 
lowering of basal phosphodiesterase activity could 
not be demonstrated with adenosine deaminase. 
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